Michael Wayne Kalb Cin Cor Pharma, Inc. (CINC) insider trading activity

Michael Wayne Kalb is EVP & Chief Financial Officer of CinCor Pharma, Inc.. Currently has a direct ownership of 0 shares of CINC, which is worth approximately $0. The most recent transaction as insider was on Feb 24, 2023, when has been sold 202,437 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Michael Wayne Kalb Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 24 2023	SELL Sale (or disposition) back to the issuer	-	202,437 Reduced 100.0%	0 Common Stock
Jan 26 2023	BUY Grant, award, or other acquisition	-	177,000 Added 46.65%	202,437 Common Stock
Nov 04 2022	BUY Grant, award, or other acquisition	-	25,437 Added 50.0%	25,437 Common Stock

Also insider at

AMRN

AMARIN CORP PLCUK Healthcare

SVP and CFO

IMPL

IMPEL PHARMACEUTICALS INC Healthcare

CFO

CPRX

CATALYST PHARMACEUTICALS, INC. Healthcare

Executive Vice President & CFO

MWK